212 related articles for article (PubMed ID: 32773247)
1. Sodium Cholate Bile Acid-Stabilized Ferumoxytol-Doxorubicin-Lipiodol Emulsion for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Kwak K; Yu B; Mouli SK; Larson AC; Kim DH
J Vasc Interv Radiol; 2020 Oct; 31(10):1697-1705.e3. PubMed ID: 32773247
[TBL] [Abstract][Full Text] [Related]
2. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads.
Choi JW; Cho HJ; Park JH; Baek SY; Chung JW; Kim DD; Kim HC
PLoS One; 2014; 9(12):e115898. PubMed ID: 25551760
[TBL] [Abstract][Full Text] [Related]
3. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients.
Song MJ; Park CH; Kim JD; Kim HY; Bae SH; Choi JY; Yoon SK; Chun HJ; Choi BG; Lee HG
Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):521-7. PubMed ID: 21537127
[TBL] [Abstract][Full Text] [Related]
5. Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin.
Boulin M; Schmitt A; Delhom E; Cercueil JP; Wendremaire M; Imbs DC; Fohlen A; Panaro F; Herrero A; Denys A; Guiu B
Eur Radiol; 2016 Feb; 26(2):601-9. PubMed ID: 26060065
[TBL] [Abstract][Full Text] [Related]
6. Stabilization Improves Theranostic Properties of Lipiodol
Deschamps F; Farouil G; Gonzalez W; Robic C; Paci A; Mir LM; Tselikas L; de Baère T
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):907-913. PubMed ID: 28271329
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular Carcinoma: Intra-arterial Delivery of Doxorubicin-loaded Hollow Gold Nanospheres for Photothermal Ablation-Chemoembolization Therapy in Rats.
Li J; Zhou M; Liu F; Xiong C; Wang W; Cao Q; Wen X; Robertson JD; Ji X; Wang YA; Gupta S; Li C
Radiology; 2016 Nov; 281(2):427-435. PubMed ID: 27347765
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
Xia X; Li X; Feng G; Zheng C; Liang H; Zhou G
Acta Radiol; 2013 Jul; 54(6):684-9. PubMed ID: 23507934
[TBL] [Abstract][Full Text] [Related]
9. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
10. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
[TBL] [Abstract][Full Text] [Related]
11. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma.
Okimoto K; Ogasawara S; Chiba T; Ooka Y; Oobu M; Azemoto R; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Yoshikawa M; Yokosuka O
Anticancer Res; 2013 Dec; 33(12):5603-9. PubMed ID: 24324105
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma.
Lilienberg E; Dubbelboer IR; Karalli A; Axelsson R; Brismar TB; Ebeling Barbier C; Norén A; Duraj F; Hedeland M; Bondesson U; Sjögren E; Stål P; Nyman R; Lennernäs H
Mol Pharm; 2017 Feb; 14(2):448-458. PubMed ID: 27997198
[TBL] [Abstract][Full Text] [Related]
14. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.
Chen R; Geschwind JF; Wang Z; Tacher V; Lin M
J Vasc Interv Radiol; 2013 Dec; 24(12):1837-44. PubMed ID: 24094672
[TBL] [Abstract][Full Text] [Related]
16. Sulfamethazine-based pH-sensitive hydrogels with potential application for transcatheter arterial chemoembolization therapy.
Lym JS; Nguyen QV; Ahn da W; Huynh CT; Jae HJ; Kim YI; Lee DS
Acta Biomater; 2016 Sep; 41():253-63. PubMed ID: 27184404
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Therapeutic Evaluation of Lenvatinib-Eluting Microspheres for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma.
Pe J; Choi B; Choi H; Kwon SW; Kim DH
Cardiovasc Intervent Radiol; 2022 Dec; 45(12):1834-1841. PubMed ID: 35962212
[TBL] [Abstract][Full Text] [Related]
19. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
[TBL] [Abstract][Full Text] [Related]
20. Nitroglycerine use in transcatheter arterial (chemo)embolization in patients with hepatocellular carcinoma and dual-energy CT assessment of Lipiodol retention.
Liu YS; Chuang MT; Tsai YS; Tsai HM; Lin XZ
Eur Radiol; 2012 Oct; 22(10):2193-200. PubMed ID: 22618520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
